Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot eye camera passes first test in clinic

NCT ID NCT07495345

Knowledge-focused Sponsor: Lightfield Medical Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new automated camera (Vscan001) that takes detailed pictures of the front of the eye. It enrolled 54 adults at one eye clinic to see if the device could successfully capture usable images without a trained photographer. The goal was to measure how many people could be imaged, not to treat any condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

54 people

The number who actually took part.

Started

Jul 2023

Finished

Sep 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults 18 years of age or older * Ability to position at the device (i.e., ability to rest chin on chinrest and forehead against forehead rest) * Willingness to provide informed consent * Patients with or without ocular pathology are eligible Exclusion Criteria: * Age younger than 18 years * Physical inability to position at the device * Movement disorders that would preclude stable positioning at the device * Significant photophobia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anterior segment of eye are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anterior segment of eye

Contacts and locations

Locations

  • Northwest Eye

    Golden Valley, Minnesota, 55416, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.